- Home
- TRIB vs NXGL Comparison
TRIB vs NXGL Comparison
Compare TRIB & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- NXGL
- Stock Information
- Founded
- TRIB 1992
- NXGL 1997
- Country
- TRIB Ireland
- NXGL United States
- Employees
- TRIB N/A
- NXGL N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NXGL Medical/Dental Instruments
- Sector
- TRIB Health Care
- NXGL Health Care
- Exchange
- TRIB Nasdaq
- NXGL Nasdaq
- Market Cap
- TRIB 24.0M
- NXGL 22.7M
- IPO Year
- TRIB N/A
- NXGL 2021
- Fundamental
- Price
- TRIB $0.80
- NXGL $4.73
- Analyst Decision
- TRIB
- NXGL
- Analyst Count
- TRIB 0
- NXGL 0
- Target Price
- TRIB N/A
- NXGL N/A
- AVG Volume (30 Days)
- TRIB 177.5K
- NXGL 168.1K
- Earning Date
- TRIB 11-15-2024
- NXGL 11-13-2024
- Dividend Yield
- TRIB N/A
- NXGL N/A
- EPS Growth
- TRIB N/A
- NXGL N/A
- EPS
- TRIB N/A
- NXGL N/A
- Revenue
- TRIB $59,126,000.00
- NXGL $6,729,000.00
- Revenue This Year
- TRIB $11.63
- NXGL $120.47
- Revenue Next Year
- TRIB $10.13
- NXGL $38.19
- P/E Ratio
- TRIB N/A
- NXGL N/A
- Revenue Growth
- TRIB N/A
- NXGL 90.57
- 52 Week Low
- TRIB $0.75
- NXGL $1.84
- 52 Week High
- TRIB $3.55
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- TRIB 27.93
- NXGL 66.45
- Support Level
- TRIB $0.75
- NXGL $4.11
- Resistance Level
- TRIB $1.01
- NXGL $5.10
- Average True Range (ATR)
- TRIB 0.11
- NXGL 0.40
- MACD
- TRIB 0.00
- NXGL 0.08
- Stochastic Oscillator
- TRIB 11.63
- NXGL 78.98
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.